TARPLIN, DOWNS & YOUNG, LLC

Lobbying for GENENTECH, INC. · Leading biotechnology co. focused on medicines for serious or life threatening conditions

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · California · House · Senate · $60,000.00 income · posted Jul 20, 2026

Lobbying activity 3

Medicare/Medicaid

Lobbying related to Medicare & Medicaid and pharmaceutical policy

Health Issues

Lobbying related to pharmaceutical policy

Budget/Appropriations

Federal budget issues

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.